Philips to expand adaptive proton therapy planning alliance with IBA

Philips has announced plans to expand its combined efforts in the adaptive proton therapy planning field with Ion Beam Applications (IBA).

The long-term collaboration between the two companies was established in 2014 and encompasses the joint marketing and sales of Philips' imaging and clinical informatics solutions in oncology alongside IBA's proton therapy solutions, as well as the joint development of new products for image-guided proton therapy and treatment modalities.

They will now jointly develop next-generation proton therapy planning methods to further increase efficiencies in the patient treatment workflow, having already secured certified compatibility between Philips' Pinnacle3 therapy planning software and IBA's proton therapy solution.

As such, more than 30 IBA proton therapy centres will now benefit from enhanced Cone Beam CT imaging technology, providing the large field-of-view needed for enhanced image guidance during proton therapy procedures.

In order to achieve this end, the partners have developed a new software algorithm with an optimised balance between speed and image quality.

Ronald de Jong, chief market leader at Philips, said: "We are delighted with the progress we have made in bringing advanced proton therapy to more people. We look forward to continuing our joint innovation efforts and making a real difference in cancer care."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.